THE KYNMOBI™ (apomorphine HCl) DIFFERENCE:

Not a pill, not an inhaler, not an injection1,2

KYNMOBI offers sublingual administration

Dosage strength represented is 20 mg. Not actual size.
3D model used for illustrative purposes only.

The first and only sublingual formulation of apomorphine.
  • The first and only sublingual formulation of apomorphine2
Avoids first‐pass metabolism when absorbed through the oral mucosa.
  • Avoids first-pass metabolism when absorbed through the oral mucosa3
Easy‐to‐carry sublingual treatment that patients can take for any individual OFF episode anytime, anywhere.
  • Easy-to-carry sublingual treatment that patients can take for any individual OFF episode anytime, anywhere.1,3*
  • *KYNMOBI should not be taken more than 5 times per day and doses should be separated by at least 2 hours.1

  • The first and only sublingual formulation of apomorphine2
  • Avoids first-pass metabolism when absorbed through the oral mucosa3
  • Easy-to-carry sublingual treatment that patients can take for any individual OFF episode anytime, anywhere.1,3*
  • *KYNMOBI should not be taken more than 5 times per day and doses should be separated by at least 2 hours.1

Dosage strength represented is 20 mg. Not actual size.
3D model used for illustrative purposes only.

Watch a short video to learn more about the route of administration for KYNMOBI

References: 1. Kynmobi. Prescribing information. Sunovion Pharmaceuticals Inc; May 2020. 2. Olanow CW, Factor SA, Espay AJ, et al; for the CTH-300 Study Investigators. Apomorphine sublingual film for off episodes in Parkinson’s disease: a randomized, double-blind, placebo-controlled phase 3 study. Lancet Neurol. 2020;19[2]:135-144. 3. CTH-300 study. Data on file. Sunovion Pharmaceuticals Inc.

Top

Thank you for registering at KYNMOBI!

We look forward to telling you more about KYNMOBI, a new medication to treat OFF episodes associated with Parkinson's disease, as it becomes available.

You have been successfully unsubscribed.

Please allow 7-10 days to process your request.